Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.40 |
| ▸ | LNPEP | Q9UIQ6 | 4/20 | 0.40 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | CD40 | P25942 | 1/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9747810 | 1.00 | SLC15A2 (0.46) | SLC15A2ERAP2LNPEPTERTSLC6A5 | |
| SCHEMBL9748489 | 1.00 | SLC15A2 (0.46) | SLC15A2ERAP2LNPEPTERTSLC6A5 | |
| SCHEMBL31433209 | 0.98 | SLC15A2 (0.45) | SLC15A2ERAP2LNPEPTERTSLC6A5 | |
| SCHEMBL31453807 | 0.96 | SLC15A2 (0.50) | SLC15A2ERAP2LNPEPTERTSLC6A5 | |
| SCHEMBL34464922 | 0.93 | SLC15A2 (0.42) | SLC15A2ERAP2LNPEPERAP1OPRD1 | |
| SCHEMBL4958843 | 0.92 | SLC15A2 (0.50) | SLC15A2ERAP2LNPEPTERTERAP1 | |
| SCHEMBL4958851 | 0.92 | SLC15A2 (0.50) | SLC15A2ERAP2LNPEPTERTERAP1 | |
| SCHEMBL8832514 | 0.92 | TERT (0.44) | SLC15A2ERAP2LNPEPTERTMMP2 | |
| SCHEMBL2823387 | 0.92 | TERT (0.44) | SLC15A2ERAP2LNPEPTERTMMP2 | |
| SCHEMBL8832652 | 0.91 | TERT (0.44) | SLC15A2ERAP2LNPEPTERTMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120943953-B | Monoclonal antibody specifically binding to EsxA and therapeutic reagent thereof | 西京学院 | 2026-05-15 | — | — | CN | claimed |
| CN-115466308-A | Anti-migration and anti-invasion 18 beta-glycyrrhetinic acid-HGK, synthesis, anti-cancer metastasis activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | claimed |
| CN-111793113-B | Synthesis, activity and application of dihydroxymethyl tetrahydrocarboline-3-formyl-The-HGK | 首都医科大学 | 2022-08-05 | — | — | CN | claimed |
| CN-112898376-B | Dioxane-modified tetrahydrocarboline-3-formyl-The-HGK, preparation thereof, antitumor activity thereof and application thereof | 首都医科大学 | 2022-06-24 | — | — | CN | claimed |
| CN-112094317-B | His-Gly-Lys modified methotrexate, synthesis, anti-transfer activity and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-112979751-B | Dioxane-modified tetrahydrocarboline-3-formyl-The-HGK, preparation thereof, anti-inflammatory activity thereof and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-112010926-B | KGH and hydroxymethyl modified benzimidazole quinazolines, synthesis, activity and applications thereof | 首都医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-112898380-B | Dioxohexa-ring modified tetrahydrocarboline-3-formyl-The-HGK, preparation thereof, antithrombotic activity thereof and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-112094322-B | His-Gly-Lys modified methotrexate, synthesis, antitumor activity and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-120943953-B | Monoclonal antibody specifically binding to EsxA and therapeutic reagent thereof | 西京学院 | 2026-05-15 | — | — | CN | disclosed |
| CN-115466308-A | Anti-migration and anti-invasion 18 beta-glycyrrhetinic acid-HGK, synthesis, anti-cancer metastasis activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-115466308-A | Anti-migration and anti-invasion 18 beta-glycyrrhetinic acid-HGK, synthesis, anti-cancer metastasis activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-115466307-A | 18 beta-glycyrrhetinic acid-Glu-Asp-Gly resistant to adhesion migration and invasion and synthesis, activity and application thereof | 首都医科大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-111793113-B | Synthesis, activity and application of dihydroxymethyl tetrahydrocarboline-3-formyl-The-HGK | 首都医科大学 | 2022-08-05 | — | — | CN | disclosed |
| EP-0522004-A1 | USE OF COPPER(II) CONTAINING COMPOUNDS TO ACCELERATE WOUND HEALING | PROCYTE CORPORATION (US) | 1993-01-13 | — | — | EP | disclosed |
| EP-0514460-A1 | ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF | PROCYTE CORPORATION (US) | 1992-11-25 | — | — | EP | disclosed |
| US-5164367-A | Complexes with peptides | PROCYTE CORPORATION (US) | 1992-11-17 | — | — | US | disclosed |
| US-5118665-A | Enhance or restore resistance of mammals to damage caused by release of reactive oxygen species | PROCYTE CORPORATION (US) | 1992-06-02 | — | — | US | disclosed |
| WO-1991014437-A2 | USE OF COPPER(II) CONTAINING COMPOUNDS TO ACCELERATE WOUND HEALING | PROCYTE CORPORATION (US) | 1991-10-03 | — | — | WO | disclosed |
| WO-1991012267-A1 | ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF | PROCYTE CORPORATION (US) | 1991-08-22 | — | — | WO | disclosed |